323 related articles for article (PubMed ID: 1685465)
1. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE
Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
[TBL] [Abstract][Full Text] [Related]
2. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
[TBL] [Abstract][Full Text] [Related]
3. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine.
Fullarton GM; Macdonald AM; McColl KE
Aliment Pharmacol Ther; 1991 Aug; 5(4):391-8. PubMed ID: 1685675
[TBL] [Abstract][Full Text] [Related]
4. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
Lanzon-Miller S; Pounder RE; Chronos NA; Raymond F; Hamilton MR; Dalgleish D
Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394
[TBL] [Abstract][Full Text] [Related]
5. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral famotidine on 24-hour intragastric acidity.
Santana IA; Lanzon-Miller S; Pounder RE
Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of 24-hour acidity by nizatidine].
Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
[TBL] [Abstract][Full Text] [Related]
8. Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?
Bauerfeind P; Cilluffo T; Fimmel CJ; Emde C; von Ritter C; Kohler W; Gugler R; Gasser T; Blum AL
Gut; 1987 May; 28(5):549-56. PubMed ID: 3596336
[TBL] [Abstract][Full Text] [Related]
9. Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin.
Smith JT; Gavey C; Nwokolo CU; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():47-63. PubMed ID: 1983346
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo.
Grimley CE; Constantinides S; Snell CC; Mills JG; Nwokolo CU
Aliment Pharmacol Ther; 1997 Oct; 11(5):875-9. PubMed ID: 9354195
[TBL] [Abstract][Full Text] [Related]
11. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo.
Grimley CE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1997 Oct; 11(5):881-5. PubMed ID: 9354196
[TBL] [Abstract][Full Text] [Related]
12. Effect of nizatidine and ranitidine on 24 hour intragastric pH, pepsin, prostaglandin E2 and serum gastrin concentrations in healthy volunteers.
Thompson A; Kirdeikis P; Jamali F; Tavernini M; Zuk L; Marriage B; Simpson I; Mahachai V
J Gastroenterol Hepatol; 1995; 10(5):546-54. PubMed ID: 8963030
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
[TBL] [Abstract][Full Text] [Related]
14. Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo.
Hamilton MI; Sercombe J; Pounder RE
Dig Dis Sci; 2002 Jan; 47(1):54-7. PubMed ID: 11837732
[TBL] [Abstract][Full Text] [Related]
15. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P
Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
[TBL] [Abstract][Full Text] [Related]
16. Twice daily nizatidine or ranitidine is superior to once daily dosing in elevating 24 h intragastric pH in patients with duodenal ulcer disease.
Thomson AB; Mahachai V; Bailey RJ; Kirdeikis P; Zuk L; Marriage B; Simpson I; Jamali F
J Gastroenterol Hepatol; 1996 Dec; 11(12):1171-6. PubMed ID: 9034938
[TBL] [Abstract][Full Text] [Related]
17. Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole.
Prewett EJ; Hudson M; Nwokolo CU; Sawyerr AM; Pounder RE
Gastroenterology; 1991 Apr; 100(4):873-7. PubMed ID: 2001826
[TBL] [Abstract][Full Text] [Related]
18. The effect of SK&F 94482 (BMY-25368) on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects.
Gavey CJ; Smith JT; Nwokolo CU; Pounder RE
Aliment Pharmacol Ther; 1989 Dec; 3(6):557-64. PubMed ID: 2577500
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
[TBL] [Abstract][Full Text] [Related]
20. The 24-hour acid suppression profile of nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Müller P; Simon B; Keohane P
Scand J Gastroenterol Suppl; 1987; 136():56-60. PubMed ID: 2892256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
